Cargando…
Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes
Secondary hyperparathyroidism (SHPT) is associated with increased bone turnover, risk of fractures, vascular calcifications, and cardiovascular and all-cause mortality. The classical treatment for SHPT includes active vitamin D compounds and phosphate binders. However, achieving the optimal laborato...
Autores principales: | Pereira, Luciano, Meng, Catarina, Marques, Daniela, Frazão, João M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798074/ https://www.ncbi.nlm.nih.gov/pubmed/29423207 http://dx.doi.org/10.1093/ckj/sfx125 |
Ejemplares similares
-
Secondary Hyperparathyroidism Disease Stabilization Following Calcimimetic Therapy
por: Frazão, João, et al.
Publicado: (2008) -
Achievement of Kidney Disease: Improving Global Outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the Photo-Graphe3 study
por: Fouque, Denis, et al.
Publicado: (2018) -
Quality of care and practice patterns in anaemia management at specialist kidney clinics in Ireland: a national study
por: Stack, Austin G, et al.
Publicado: (2018) -
CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018) -
Sevelamer reduces endothelial inflammatory response to advanced glycation end products
por: Gregório, Paulo C, et al.
Publicado: (2018)